Oncotelic Therapeutics, Inc. (OTLC): Shares Outstanding
442.60M
As of 2025-12-31
457.01M
As of 2026-06-30
+4.1%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 442.60M | +8.7% | 2026-04-15, Balance as of period end |
| 2024-12-31 | 407.29M | +2.0% | 2026-04-15, Balance as of period end |
| 2023-12-31 | 399.18M | +1.9% | 2025-04-15, Balance as of period end |
| 2022-12-31 | 391.85M | +4.4% | 2024-04-12, Balance as of period end |
| 2021-12-31 | 375.29M | n/c | 2023-04-20, Balance as of period end |
| 2020-12-31 | 90.60M | +7.8% | 2022-04-15, Balance as of period end |
| 2019-12-31 | 84.07M | n/m | 2021-04-15, Balance as of period end |
| 2018-12-31 | 6.84M | n/c | 2020-05-14, Balance as of period end |
| 2017-12-31 | 26.55M | 0.0% | 2019-04-10, Balance as of period end |
| 2016-12-31 | 26.55M | 0.0% | 2018-04-17, Balance as of period end |
| 2015-12-31 | 26.55M | +28.2% | 2017-03-30, Balance as of period end |
| 2014-12-31 | 20.70M | +270.7% | 2016-03-25, Balance as of period end |
| 2013-12-31 | 5.59M | +219.9% | 2015-03-30, Balance as of period end |
| 2012-12-31 | 1.75M | +38.0% | 2014-03-20, Balance as of period end |
| 2011-12-31 | 1.26M | -77.0% | 2013-03-15, Balance as of period end |
| 2010-12-31 | 5.50M | n/a | 2012-03-28, Balance as of period end |